Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit

      Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit

      Ruby Khatun Khatun22 Nov 2017 10:00 AM IST
      ZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
      WHO names Zydus oral anemia developmental candidate: Pankaj Patel

      WHO names Zydus oral anemia developmental candidate: Pankaj Patel

      Ruby Khatun Khatun21 Nov 2017 3:00 PM IST
      Ahmedabad: Zydus Cadila announced that the WHO INN committee has granted the name Desidustat to its Phase II anemia candidate, ZYAN1. The INN system...
      Biocon shares up 7 percent as facility gets inspection closure report

      Biocon shares up 7 percent as facility gets inspection closure report

      Ruby Khatun Khatun21 Nov 2017 10:30 AM IST
      New Delhi: Shares of biotechnology firm Biocon surged over 7 percent after the company said it has received an EIR from the USFDA on the closure of...
      Cipla gets USFDA approval for generic Dacogen to treat myelodysplastic syndromes

      Cipla gets USFDA approval for generic Dacogen to treat myelodysplastic syndromes

      Ruby Khatun Khatun21 Nov 2017 10:15 AM IST
      New Delhi: Drug major Cipla has received final approval from the US health regulator for the generic version of Dacogen, indicated for the treatment...
      GSK Health names Navneet Saluja as India Sub-continent head

      GSK Health names Navneet Saluja as India Sub-continent head

      Ruby Khatun Khatun21 Nov 2017 10:01 AM IST
      New Delhi: GSK Consumer Healthcare announced the appointment of Navneet Saluja as the Area General Manager for India Sub-continent.Saluja, who...
      Abbott’s Quality of Survival survey finds a positive impact on pre-term babies health

      Abbott’s Quality of Survival survey finds a positive impact on pre-term babies health

      Ruby Khatun Khatun21 Nov 2017 9:45 AM IST
      MUMBAI: A new survey conducted by Abbott in mothers of pre-term babies, calls for the heightened focus on nutrition and the need for counseling of...
      Care N Grow to launch cloud-based health service for students

      Care N Grow to launch cloud-based health service for students

      Ruby Khatun Khatun21 Nov 2017 9:30 AM IST
      Hyderabad: Care N Grow, a start-up incubated in famed T-Hub, in Hyderabad has announced that a subscription-based preventive health and behaviour...
      India-Canada joint venture in medical electronics to ensure affordable healthcare

      India-Canada joint venture in medical electronics to ensure affordable healthcare

      Ruby Khatun Khatun21 Nov 2017 9:15 AM IST
      New Delhi: Unique Broadband Systems Ltd, UBS, of Toronto, Ontario, Canada and Kaynes Technology of Mysore, India, was awarded funding by the Global...
      Sanofi Pasteurs Expired polio vaccines being used in Gujarat: Probe demanded

      Sanofi Pasteurs Expired polio vaccines being used in Gujarat: Probe demanded

      Ruby Khatun Khatun20 Nov 2017 5:35 PM IST
      25,000 doses of IPV are on the last VVM stage, stated a letter to the health departmentAhmedabad: Injectable Polio Vaccine supplied to the hospitals...
      Divis Lab Vizag unit gets USFDA EIR with 6 observations

      Divis Lab Vizag unit gets USFDA EIR with 6 observations

      Ruby Khatun Khatun20 Nov 2017 10:45 AM IST
      New Delhi: Drug firm Divis Laboratories on Saturday said it has received an establishment inspection report (EIR) from the US health regulator for its...
      Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa

      Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa

      Ruby Khatun Khatun20 Nov 2017 10:18 AM IST
      Mumbai: Leading private sector hospital chain Narayana Hrudayalaya has chalked out a Rs 500 crore expansion plan, which will see it entering...
      FDA expands approval for Pfizer cancer drug Studnt

      FDA expands approval for Pfizer cancer drug Studnt

      Ruby Khatun Khatun20 Nov 2017 10:07 AM IST
      The U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok